• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名年轻男性的自发性血栓形成揭示了抗磷脂综合征与双杂合型亚甲基四氢叶酸还原酶(MTHFR)突变伴高同型半胱氨酸血症的罕见共存情况。

Unprovoked Thrombosis in a Young Male Revealing a Rare Coexistence of Antiphospholipid Syndrome and Double Heterozygous MTHFR Mutation With Hyperhomocysteinemia.

作者信息

Lakshme Iswarya, C Avinash, Senthil N, Pandurangan Viswanathan

机构信息

Internal Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

General Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

出版信息

Cureus. 2025 Aug 16;17(8):e90260. doi: 10.7759/cureus.90260. eCollection 2025 Aug.

DOI:10.7759/cureus.90260
PMID:40964586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12436970/
Abstract

A case of acute pulmonary thromboembolism (PTE) in a 39-year-old male who presented with progressive dyspnea and left lower limb pain. Imaging studies confirmed extensive pulmonary and deep venous thrombosis. A hypercoagulability workup revealed primary antiphospholipid syndrome (APS) with positive lupus anticoagulant and beta-2 glycoprotein antibodies, along with a compound heterozygous methylenetetrahydrofolate reductase (MTHFR) mutation and hyperhomocysteinemia. This case highlights the significant thrombotic risk posed by the co-occurrence of APS and the compound heterozygous MTHFR mutation. Early identification of such overlapping thrombophilic conditions is crucial for prompt management and effective secondary prevention.

摘要

一名39岁男性急性肺血栓栓塞症(PTE)病例,该患者表现为进行性呼吸困难和左下肢疼痛。影像学检查证实存在广泛的肺和深静脉血栓形成。一项高凝状态检查显示原发性抗磷脂综合征(APS),狼疮抗凝物和β-2糖蛋白抗体呈阳性,同时存在复合杂合子亚甲基四氢叶酸还原酶(MTHFR)突变和高同型半胱氨酸血症。该病例突出了APS与复合杂合子MTHFR突变同时存在所带来的显著血栓形成风险。早期识别此类重叠的易栓症对于及时处理和有效的二级预防至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a29/12436970/417fe00fe695/cureus-0017-00000090260-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a29/12436970/0bcef4efe3fe/cureus-0017-00000090260-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a29/12436970/417fe00fe695/cureus-0017-00000090260-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a29/12436970/0bcef4efe3fe/cureus-0017-00000090260-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a29/12436970/417fe00fe695/cureus-0017-00000090260-i02.jpg

相似文献

1
Unprovoked Thrombosis in a Young Male Revealing a Rare Coexistence of Antiphospholipid Syndrome and Double Heterozygous MTHFR Mutation With Hyperhomocysteinemia.一名年轻男性的自发性血栓形成揭示了抗磷脂综合征与双杂合型亚甲基四氢叶酸还原酶(MTHFR)突变伴高同型半胱氨酸血症的罕见共存情况。
Cureus. 2025 Aug 16;17(8):e90260. doi: 10.7759/cureus.90260. eCollection 2025 Aug.
2
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.抗血小板和抗凝药物用于抗磷脂抗体个体血栓形成的一级预防。
Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
3
Thrombotic Antiphospholipid Syndrome: Recurrent Thromboses.血栓形成性抗磷脂综合征:复发性血栓形成
Dokl Biochem Biophys. 2025 May 11. doi: 10.1134/S1607672925700152.
4
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.抗血小板和抗凝药物用于抗磷脂综合征患者中风和其他血栓栓塞事件的二级预防。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD012169. doi: 10.1002/14651858.CD012169.pub2.
5
Spontaneous resolution of foramen magnum dural arteriovenous fistula with anticoagulant therapy: A case of antiphospholipid syndrome misdiagnosed as seronegative neuromyelitis optica spectrum disorder.抗凝治疗使枕骨大孔区硬脑膜动静脉瘘自发消退:1例抗磷脂综合征误诊为血清阴性视神经脊髓炎谱系障碍的病例
Surg Neurol Int. 2025 Jun 20;16:252. doi: 10.25259/SNI_308_2025. eCollection 2025.
6
Prothrombin Thrombophilia凝血酶原血栓形成倾向
7
Clinical characteristics of patients with acute pulmonary embolism complicated with antiphospholipid syndrome: a case control study.急性肺栓塞合并抗磷脂综合征患者的临床特征:一项病例对照研究
BMC Pulm Med. 2025 Jul 28;25(1):357. doi: 10.1186/s12890-025-03815-6.
8
Management of antiphospholipid antibody syndrome: a systematic review.抗磷脂抗体综合征的管理:一项系统综述。
JAMA. 2006 Mar 1;295(9):1050-7. doi: 10.1001/jama.295.9.1050.
9
Coexistence of Congenital Dysfibrinogenemia and Antiphospholipid Syndrome in Pregnancy: A Case Report.孕期先天性异常纤维蛋白原血症与抗磷脂综合征并存:一例报告
Int J Womens Health. 2025 Sep 4;17:2885-2890. doi: 10.2147/IJWH.S528071. eCollection 2025.
10
Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome.抗磷脂综合征不同临床类型中的标准和非标准抗磷脂抗体
Front Immunol. 2025 Aug 1;16:1636171. doi: 10.3389/fimmu.2025.1636171. eCollection 2025.

本文引用的文献

1
Hypercoagulability and the A1298C MTHFR Mutation: Case Series of Unexplained Pulmonary Embolism.高凝状态与A1298C亚甲基四氢叶酸还原酶突变:不明原因肺栓塞病例系列
Methodist Debakey Cardiovasc J. 2025 May 30;21(1):57-62. doi: 10.14797/mdcvj.1565. eCollection 2025.
2
Antiphospholipid syndrome.抗磷脂综合征。
Lancet. 2010 Oct 30;376(9751):1498-509. doi: 10.1016/S0140-6736(10)60709-X. Epub 2010 Sep 6.
3
Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians.
高同型半胱氨酸血症和亚甲基四氢叶酸还原酶的复合杂合状态是南印度人深静脉血栓形成的独立危险因素。
Blood Coagul Fibrinolysis. 2007 Mar;18(2):113-7. doi: 10.1097/MBC.0b013e3280108e01.
4
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).关于明确抗磷脂综合征(APS)分类标准更新的国际共识声明。
J Thromb Haemost. 2006 Feb;4(2):295-306. doi: 10.1111/j.1538-7836.2006.01753.x.
5
Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85.热不稳定亚甲基四氢叶酸还原酶基因与85岁以上人群认知障碍风险
J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):535-8. doi: 10.1136/jnnp.67.4.535.
6
Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR).男性的死亡风险与亚甲基四氢叶酸还原酶基因(MTHFR)的一种常见突变有关。
Eur J Hum Genet. 1999 Feb-Mar;7(2):197-204. doi: 10.1038/sj.ejhg.5200283.